Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration. - Wikidata - thesis-toulmin - TriplyDB

Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration.

Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration.

http://www.wikidata.org/entity/Q30833907

about

Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study.Cataract surgery after intravitreal injection of triamcinolone acetonide.Future pharmacological treatment options for nonexudative and exudative age-related macular degeneration.Intraocular pressure after intravitreal injection of triamcinolone acetonide.Intravitreal triamcinolone acetonide for exudative age related macular degeneration.Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration.Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration.Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye Macular atrophy after combined intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization.Immunological factors in the pathogenesis and treatment of age-related macular degeneration.Intravitreal triamcinolone acetonide: a change in a paradigm.Visual acuity and intraocular pressure after high-dose intravitreal triamcinolone acetonide in selected ocular diseases.Use of intravitreal injection of triamcinolone acetonide in the treatment of age-related macular degeneration.Intraocular pressure following intravitreal injection of triamcinolone acetonide.The use of intraocular corticosteroids.Intraocular corticosteroids for posterior segment disease: 2012 update.Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo.Effect of photodynamic therapy with posterior sub-tenon triamcinolone acetonide on predominantly classic choroidal neovascularization: one-year results.Are we overlooking the side effects of the drugs in our zeal to conquer ARMD?Intravitreal triamcinolone in recurrence of choroidal neovascularisation.Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study.Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration.Repeated intravitreal injection of triamcinolone for exudative age-related macular degeneration.Systemic immunosuppression and risk of age-related macular degeneration

P2860

Q24201624-91498F67-1581-43CA-8849-0F672285F77D Q24243503-D4343BB7-7431-44FF-B6EB-F9530D579A13 Q31148660-68D30A15-408D-4D1B-9A70-8998D526B875 Q33201157-8CFBAC36-C6A3-4A07-95D3-19542B8308F7 Q33212693-64ABA5DE-9C9F-4097-92A7-87EED4EA2E07 Q35590421-334A7BEB-84FE-4B9C-BF34-3DBDD036BC70 Q35590749-7D560DB6-C88D-45F0-AEAD-536026B3D11D Q35591813-9186965D-CF25-4E7B-93F2-7F61395486AF Q35592674-1ACBA550-1170-4674-B3F0-045328D226B6 Q35769376-26888AE3-C5D4-4C20-A4C1-B80D2E29DCE6 Q35924041-1CC9207E-3F0C-4955-80A6-0CCE07789848 Q36086191-4144F69B-C325-4C9C-A4E2-7451A9944088 Q36500994-3B28F3B1-B3E5-4A6D-A5F6-4EAA0C2DE6C0 Q36737173-FE90875B-5CF9-4915-BF17-A1992856D201 Q36977430-B6B54BE1-AF7A-402D-9A0B-8C88C63A63B9 Q37223023-9548707C-EF71-4D75-B32E-6B5925ECC847 Q37598893-57CCBB49-DE5D-43E2-9E8C-B61B79F2ECA1 Q38025444-8EF5FCB6-E5A3-4946-970C-075F4682BD03 Q42026811-C09A3E9C-CC3D-47D4-B514-02696DE8483C Q42556381-BA940BAD-1779-4C7E-BD97-602E31EC2C22 Q42930844-BE2449C8-548B-40CB-8B14-7D1AFDA7F650 Q43009470-3E33E484-5E4F-4323-8BF1-76F6095EAAA6 Q44952432-EDE2E300-1409-43C3-BCBA-D601B8E8C4F2 Q46893247-AB46A1E6-7F1A-4FAE-9B38-1E1DCCA580B8 Q53790301-7D82500A-10D9-4873-8C1C-F54858D980F4 Q58713704-EA19E326-D4BA-4F6F-845C-F114901EF226

P2860

Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration.

http://www.wikidata.org/entity/Q30833907

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Intravitreal triamcinolone in ...... tment in macular degeneration.

@ast

Intravitreal triamcinolone in ...... tment in macular degeneration.

@en

type

label

Intravitreal triamcinolone in ...... tment in macular degeneration.

@ast

Intravitreal triamcinolone in ...... tment in macular degeneration.

@en

prefLabel

Intravitreal triamcinolone in ...... tment in macular degeneration.

@ast

Intravitreal triamcinolone in ...... tment in macular degeneration.

@en

P1433

Q30833907-DF81123F-672A-4984-A1A5-CD10767C43B0

P1476

Q30833907-8F0DCEDD-E571-4554-8F17-3ED323206D9D

P2093

Q30833907-360E5597-12B6-4FFD-8E0A-52C04B8154E2

Q30833907-41642EE7-FC8F-4F55-B83B-3D5D300932B3

Q30833907-7C25B656-2A5D-48B6-8F24-CBED9F7BF3F3

Q30833907-82492CF0-C58B-401B-8B0F-669524E34536

P2860

Q30833907-115F7CFA-68B1-447C-8E9B-F15520346C2C

Q30833907-400B01DC-2230-4A57-8499-408B78BCDEE0

Q30833907-C2896C05-8D85-4431-BD4A-5DF0BEAB8740

Q30833907-D9B9C3BA-6CDD-43BE-B7C4-5A3B604E671B

Q30833907-FCA034F0-8414-49A9-ABED-D688FAA8874B

P304

Q30833907-588729A7-2AA1-4356-B8B4-D7F9FBEE61BD

P31

Q30833907-88756C4B-D4EF-446E-ADC0-21DEE829E152

P356

Q30833907-ACDA444A-7010-4615-A68E-303C4A301E94

P407

Q30833907-1AEB6F65-BBAD-466D-8D90-96E2C9AE08AF

P433

Q30833907-D1A301CC-0322-46D1-B993-7211555ED6A8

P478

Q30833907-F1C90B22-C8AD-4D86-8939-67A7E3F0F8AB

P577

Q30833907-E41C4A9A-AB42-40AC-96F5-21AB9F14355A

P5875

Q30833907-C3F5FA2D-C045-4526-BA48-51E56D0457C5

P698

Q30833907-3EEFE8C1-B0AF-4537-8D90-7DAF594CFA7A

P921

Q30833907-BD8D339A-43C2-403C-9B41-01A8C973AABC

P932

Q30833907-71643C0A-15D5-488C-A0AC-A31891B02EE4

P356

P1433

British Journal of Ophthalmology

P1476

Intravitreal triamcinolone in ...... tment in macular degeneration.

@en

P2093

L Pratt

http://www.w3.org/2001/XMLSchema#string

N T Ranson

http://www.w3.org/2001/XMLSchema#string

R P Danis

http://www.w3.org/2001/XMLSchema#string

T A Ciulla

http://www.w3.org/2001/XMLSchema#string

P2860

Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration

Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model.

Exudative macular degeneration and intravitreal triamcinolone. A pilot study.

Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy.

P304

527-529

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJO.86.5.527

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277547798

http://www.w3.org/2001/XMLSchema#string

P698

11973247

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization

P932

1771118

http://www.w3.org/2001/XMLSchema#string